Prospective Urban and Rural Epidemiological Study (PURE)
The aim of the PURE study is to examine the impact of urbanisation on the development of primordial risk factors (e.g., physical activity and nutrition changes), primary risk factors (e.g., obesity, hypertension, dysglycemia and dyslipidemia, smoking), and cardiovascular disease (CVD). The PURE study is observational in design and has been running for over 20 years thus far. A total of 225,000 household members throughout 27 countries have participated. The participating countries are Argentina, Bangladesh, Brazil, Canada, Chile, China, Colombia, Ecuador, India, Iran, Kazakhstan, Kyrgyzstan, Malaysia, Pakistan, Palestine, Peru, Philippines, Poland, Russia, Saudi Arabia, South Africa, Sweden, Tanzania, Turkey, United Arab Emirates, Uruguay, and Zimbabwe.
Study design
Community or village panel, Household panel, Cohort
Number of participants at first data collection
225,000 (participants)
Recruitment is ongoing
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2001
Primary Institutions
Hamilton Health Sciences
McMaster University
Population Health Research Institute (PHRI)
Profile paper DOI
Not available
Funders
AstraZeneca
Boehringer Ingelheim
Canadian Institutes of Health Research (CIHR, Instituts de recherche en santé du Canada, IRSC)
GlaxoSmithKline (GSK)
Hamilton Health Sciences
Ongoing?
Yes
Data types collected
- Interview – face-to-face
- Interview – phone
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- None
- None
- Healthcare data
- Mortality data
Engagement
Keywords
